Quarterly report pursuant to Section 13 or 15(d)

Net Loss per Common Share (Tables)

v3.19.3
Net Loss per Common Share (Tables)
9 Months Ended
Sep. 30, 2019
Net Loss per Common Share  
Schedule of diluted weighted average shares outstanding

The following shares of potentially dilutive securities have been excluded from the computations of diluted weighted average shares outstanding, as the effect of including such securities would be anti-dilutive at the end of the nine months ended September 30, 2019 and 2018:

 

 

 

 

 

 

 

    

Nine Months Ended September 30, 

 

 

2019

 

2018

Warrants to purchase Common Stock

 

865,364

 

890,892

Opus warrants to purchase Common Stock

 

1,880,000

 

1,880,000

Options to purchase Common Stock

 

1,169,293

 

1,085,502

Convertible preferred stock

 

1,002,087

 

1,000,000

Unvested Restricted Stock

 

12,622,881

 

11,014,596

Unvested Restricted Stock Units

 

791,610

 

1,796,134

Total

 

18,331,235

 

17,667,124